Multiplexed DNA Assembly for Bacterial Mutation Tracking
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for tracking combinations of genetic mutations in cell populations are time-consuming, costly, and limited in their ability to identify subtle fitness changes and rare mutants, often resulting in crossover noise that reduces effectiveness.
Innovation Solution
A new approach that couples DNA assembly with paired-end sequencing technology, using unique barcodes on high-copy plasmids to identify and quantify mutations across multiple sites with high sensitivity and accuracy, decoupling quantification and qualification for higher resolution and efficiency.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of manufacture
If restriction and ligation enzyme-based methods are used for assembling diverse genetic elements, then DNA assembly can be achieved, but the process becomes time-consuming and laborious with limited throughput
Solution Approach 1:
The patent replaces traditional restriction enzyme-based mechanical DNA assembly methods with a PCR-based amplification system. Unique PCR primers with specific sequences amplify target DNA fragments, and these fragments are assembled through homologous recombination or direct ligation without requiring restriction enzyme digestion and ligase activity, thereby dramatically increasing throughput and reducing manual intervention
Solution Approach 2:
The patent uses PCR amplification to generate multiple copies of target DNA fragments with specific sequences. By copying the essential information (DNA sequences) through amplification rather than physical manipulation, the system achieves high-throughput assembly of numerous genetic elements simultaneously, overcoming the bottleneck of traditional one-by-one cloning methods
2Productivity
If multiplex PCR with unrelated nucleotide sequences is used to amplify multiple DNA segments, then simultaneous amplification can be achieved, but identical unrelated sequences must be removed or extended before linking
Solution Approach 1:
The patent applies local quality by designing PCR primers with unique, site-specific nucleotide sequences rather than using identical unrelated sequences. Each primer pair targets a specific DNA fragment with its own unique sequence tags, allowing multiple fragments to be amplified simultaneously while maintaining individual sequence identities. This eliminates the need for subsequent removal or extension of universal tags, reducing processing complexity
Solution Approach 2:
The patent segments the DNA amplification process into independent fragment-specific PCR reactions, where each fragment is amplified with its own unique primers. This segmentation allows each DNA fragment to be processed independently with customized sequences, enabling simultaneous amplification of multiple targets without requiring a universal sequence framework that would complicate downstream assembly
3Ease of manufacture
If splicing by overlap extension is used to assemble DNA molecules at precise junctions, then restriction enzymes and ligase are avoided, but primer design becomes increasingly complex as the number of fragments increases
Solution Approach 1:
The patent implements universality by using a standardized PCR amplification protocol that can handle any number of DNA fragments simultaneously. The same basic primer design principles and thermal cycling conditions apply regardless of whether 3, 6, or 12 fragments are being assembled, making the method universally applicable and avoiding the need to redesign the entire assembly process for different fragment numbers
Solution Approach 2:
The patent simplifies the system by changing the key parameter from complex overlapping primer sequences to simple, non-overlapping PCR primers with unique identification sequences. By adjusting the primer design parameters to avoid overlap requirements, the method maintains enzyme-free assembly benefits while dramatically reducing primer design complexity, allowing straightforward assembly of many fragments
4Measurement precision
If traditional genotyping methods are used to assess genetic mutations, then individual mutations can be identified, but combinations of mutations in heterogeneous populations cannot be adequately assessed
Solution Approach 1:
The patent merges multiple genotyping capabilities into a single high-throughput sequencing assay. By combining PCR amplification of multiple target fragments, library preparation, and next-generation sequencing, the system can simultaneously detect and characterize combinations of mutations across many genes in heterogeneous cell populations, rather than assessing individual mutations in separate experiments
Solution Approach 2:
The patent uses PCR amplification to generate sufficient copies of DNA from heterogeneous cell populations, enabling sequencing of rare mutants. The amplification process preserves the combinatorial mutation information present in individual cells, allowing high-resolution assessment of mutation combinations that would be undetectable in bulk DNA without amplification
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
Enables the identification of an unlimited number of sites with reduced crossover noise, providing highly sensitive and quantitative tracking of mutations, facilitating the assessment of combinatorial mutation spaces and subtle fitness changes in cell populations.
Implementation Method 1
Multiplex polymerase chain reaction (PCR) using primers tagged with unrelated nucleotide sequences
Implementation Method 2
restriction and ligation enzyme-based methods
Implementation Method 3
restriction and ligation enzyme-based methods
Data Source
AI summary
Compositions and methods for tracking combinations of mutations in populations by coupling DNA assembly and paired-end sequencing technology with high-throughput sequencing. This allows for an unlimited number of mutation sites in a population of microorganisms to be identified, and allows sites to be sequenced across several replicates. Unique identifiers (DNA barcodes) can be used to measure fitness data by sequencing of the barcodes multiplexed with the mutation sites with high-throughput short sequencing read technology, allowing selections to be rapidly performed on populations of known combinatorial genotypes.